These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8691109)

  • 21. Nicotine stimulates osteoclast resorption in a porcine marrow cell model.
    Henemyre CL; Scales DK; Hokett SD; Cuenin MF; Peacock ME; Parker MH; Brewer PD; Chuang AH
    J Periodontol; 2003 Oct; 74(10):1440-6. PubMed ID: 14653389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
    van't Hof RJ; Ralston SH
    J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophage colony stimulating factor increases bone resorption in dispersed osteoclast cultures by increasing osteoclast size.
    Lees RL; Heersche JN
    J Bone Miner Res; 1999 Jun; 14(6):937-45. PubMed ID: 10352102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wortmannin inhibits spreading and chemotaxis of rat osteoclasts in vitro.
    Pilkington MF; Sims SM; Dixon SJ
    J Bone Miner Res; 1998 Apr; 13(4):688-94. PubMed ID: 9556069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PPAR agonists modulate human osteoclast formation and activity in vitro.
    Chan BY; Gartland A; Wilson PJ; Buckley KA; Dillon JP; Fraser WD; Gallagher JA
    Bone; 2007 Jan; 40(1):149-59. PubMed ID: 17010686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor.
    Mentaverri R; Kamel S; Wattel A; Prouillet C; Sevenet N; Petit JP; Tordjmann T; Brazier M
    J Cell Biochem; 2003 Apr; 88(6):1145-56. PubMed ID: 12647297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
    Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
    J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. S 12911-2 inhibits osteoclastic bone resorption in vitro.
    Takahashi N; Sasaki T; Tsouderos Y; Suda T
    J Bone Miner Res; 2003 Jun; 18(6):1082-7. PubMed ID: 12817762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Luteolin inhibition of V-ATPase a3-d2 interaction decreases osteoclast resorptive activity.
    Crasto GJ; Kartner N; Yao Y; Li K; Bullock L; Datti A; Manolson MF
    J Cell Biochem; 2013 Apr; 114(4):929-41. PubMed ID: 23129004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
    Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
    Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 17beta-estradiol downregulates beta3-integrin expression in differentiating and mature human osteoclasts.
    Saintier D; Burde MA; Rey JM; Maudelonde T; de Vernejoul MC; Cohen-Solal ME
    J Cell Physiol; 2004 Feb; 198(2):269-76. PubMed ID: 14603529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats.
    Turner RT; Wakley GK; Hannon KS; Bell NH
    Endocrinology; 1988 Mar; 122(3):1146-50. PubMed ID: 3342747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts.
    Horton MA; Taylor ML; Arnett TR; Helfrich MH
    Exp Cell Res; 1991 Aug; 195(2):368-75. PubMed ID: 1712731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro osteoclast resorption of bone substitute biomaterials used for implant site augmentation: a pilot study.
    Taylor JC; Cuff SE; Leger JP; Morra A; Anderson GI
    Int J Oral Maxillofac Implants; 2002; 17(3):321-30. PubMed ID: 12074446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of calmodulin and protein kinase C antagonists on bone resorption and acid transport activity.
    Williams JP; Thames AM; McKenna MA; McDonald JM
    Calcif Tissue Int; 2003 Sep; 73(3):290-6. PubMed ID: 14667143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells.
    Guo C; Hou GQ; Li XD; Xia X; Liu DX; Huang DY; Du SX
    Cell Physiol Biochem; 2012; 30(1):123-36. PubMed ID: 22759961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colony stimulating factor-1 plays a role in osteoclast formation and function in bone resorption induced by parathyroid hormone and parathyroid hormone-related protein.
    Weir EC; Lowik CW; Paliwal I; Insogna KL
    J Bone Miner Res; 1996 Oct; 11(10):1474-81. PubMed ID: 8889847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brefeldin A inhibits osteoclastic bone resorption through induction of apoptosis.
    Niwa S; Ishibashi O; Inui T
    Life Sci; 2001 Dec; 70(3):315-24. PubMed ID: 12005264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tamoxifen inhibits phorbol ester stimulated osteoclastic bone resorption: an effect mediated by calmodulin.
    Williams JP; McKenna MA; Thames AM; McDonald JM
    Biochem Cell Biol; 2000; 78(6):715-23. PubMed ID: 11206583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Echistatin is a potent inhibitor of bone resorption in culture.
    Sato M; Sardana MK; Grasser WA; Garsky VM; Murray JM; Gould RJ
    J Cell Biol; 1990 Oct; 111(4):1713-23. PubMed ID: 2211834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.